102 Conversely, numerous teams are advocating for your incorporation of novel markers, for instance a intricate karyotype55 or epigenetic subsets, 27,28 into scientific practice. Every one of these novel prognostic and/or predictive products will need to be validated in cohorts of sufferers dealt with with targeted agents.It is necessary to conside